Home RxNorm 1716094 betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1716094
RxNorm name betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam
Display name Betamethasone/Calcipotriene (Topical)
Full name betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam
Term type SCD
Status Active
Strength 0.0643-0.005%
Dose form Foam
Route Topical
Updated 2026-10-21 00:29:18 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 112015
Active start 112015
Multiple ingredient YES
Branded NO Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength betamethasone dipropionate 0.643 MG / 1 ML betamethasone betamethasone dipropionate calcipotriene 0.05 MG / 1 ML calcipotriene calcipotriene
Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ENSTILAR CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE LEO Pharma Inc. d1193df2-d53f-4342-bd9d-d9cba7c89709 2021-10-18 Warnings, Adverse reactions Exact identifier rxcui: 1716094
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective d1193df2-d53f-4342-bd9d-d9cba7c89709 calcipotriene 0.005 % / betamethasone propionate 0.064 % Topical Foam [PSN] · betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam [SCD] · calcipotriene 0.005 % / betamethasone propionate 0.064 % Topical Foam [SY] 3 15 These highlights do not include all the information needed to use ENSTILAR Foam safely and effectively. See full prescribing information for ENSTILAR Foam. ENSTILAR ® (calcipotriene and betamethasone dipropionate) foam, for topical use Initial U.S. Approval: 2006 20211018
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC C05AA Corticosteroids ATC1-4 betamethasone ATC S03BA Corticosteroids ATC1-4 betamethasone ATC S02BA Corticosteroids ATC1-4 betamethasone ATC R01AD Corticosteroids ATC1-4 betamethasone ATC A07EA Corticosteroids acting locally ATC1-4 betamethasone ATC S01BA Corticosteroids, plain ATC1-4 betamethasone ATC D07AC Corticosteroids, potent (group III) ATC1-4 betamethasone ATC D07XC Corticosteroids, potent, other combinations ATC1-4 betamethasone ATC S01CB Corticosteroids/antiinfectives/mydriatics in combination ATC1-4 betamethasone ATC R03BA Glucocorticoids ATC1-4 betamethasone ATC H02AB Glucocorticoids ATC1-4 betamethasone ATC D05AX Other antipsoriatics for topical use ATC1-4 calcipotriene FDASPL D014807 Vitamin D CHEM has_chemical_structure calcipotriene FDASPL N0000175576 Corticosteroid EPC has_epc betamethasone FDASPL N0000175849 Vitamin D Analog EPC has_epc calcipotriene FDASPL N0000175450 Corticosteroid Hormone Receptor Agonists MOA has_moa betamethasone MEDRT D001623 Betamethasone CHEM has_ingredient betamethasone dipropionate MEDRT D001623 Betamethasone CHEM has_ingredient betamethasone MEDRT D002117 Calcitriol CHEM has_ingredient calcipotriene MEDRT D003876 Dermatitis, Atopic DISEASE may_treat betamethasone MEDRT D003876 Dermatitis, Atopic DISEASE may_treat betamethasone dipropionate MEDRT D012628 Dermatitis, Seborrheic DISEASE may_treat betamethasone dipropionate MEDRT D012628 Dermatitis, Seborrheic DISEASE may_treat betamethasone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with betamethasone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with calcipotriene MEDRT D004342 Drug Hypersensitivity DISEASE ci_with betamethasone dipropionate MEDRT D005148 Facial Dermatoses DISEASE may_treat betamethasone MEDRT D005148 Facial Dermatoses DISEASE may_treat betamethasone dipropionate MEDRT D005533 Foot Dermatoses DISEASE may_treat betamethasone MEDRT D005533 Foot Dermatoses DISEASE may_treat betamethasone dipropionate MEDRT D006229 Hand Dermatoses DISEASE may_treat betamethasone dipropionate MEDRT D006229 Hand Dermatoses DISEASE may_treat betamethasone MEDRT D006934 Hypercalcemia DISEASE ci_with calcipotriene MEDRT D007249 Inflammation DISEASE may_treat betamethasone dipropionate MEDRT D007249 Inflammation DISEASE may_treat betamethasone MEDRT D007868 Leg Dermatoses DISEASE may_treat betamethasone dipropionate MEDRT D007868 Leg Dermatoses DISEASE may_treat betamethasone MEDRT D009181 Mycoses DISEASE ci_with betamethasone MEDRT D009181 Mycoses DISEASE ci_with betamethasone dipropionate MEDRT D011538 Pruritus Ani DISEASE may_treat betamethasone MEDRT D011538 Pruritus Ani DISEASE may_treat betamethasone dipropionate MEDRT D011565 Psoriasis DISEASE may_treat betamethasone MEDRT D011565 Psoriasis DISEASE may_treat calcipotriene MEDRT D011565 Psoriasis DISEASE may_treat betamethasone dipropionate MEDRT D016553 Purpura, Thrombocytopenic, Idiopathic DISEASE ci_with betamethasone MEDRT D016553 Purpura, Thrombocytopenic, Idiopathic DISEASE ci_with betamethasone dipropionate MEDRT D012536 Scalp Dermatoses DISEASE may_treat betamethasone MEDRT D012536 Scalp Dermatoses DISEASE may_treat betamethasone dipropionate MEDRT N0000000163 Enzyme Interactions MOA has_moa calcipotriene MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa betamethasone MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa betamethasone dipropionate MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa betamethasone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa betamethasone dipropionate MEDRT N0000008297 Antipruritic Activity PE has_pe betamethasone dipropionate MEDRT N0000008297 Antipruritic Activity PE has_pe betamethasone MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe betamethasone dipropionate MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe betamethasone MEDRT N0000009928 Decreased Cellular Migration PE has_pe betamethasone MEDRT N0000009928 Decreased Cellular Migration PE has_pe betamethasone dipropionate MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe betamethasone dipropionate MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe betamethasone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe betamethasone dipropionate MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe betamethasone MEDRT N0000008700 Decreased Lysosomal Function PE has_pe betamethasone MEDRT N0000008700 Decreased Lysosomal Function PE has_pe betamethasone dipropionate MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe betamethasone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe betamethasone dipropionate MEDRT N0000008841 Decreased Protein Synthesis PE has_pe betamethasone MEDRT N0000008841 Decreased Protein Synthesis PE has_pe betamethasone dipropionate MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe betamethasone dipropionate MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe betamethasone MEDRT N0000009933 Increased Vitamin Uptake and Modification PE has_pe calcipotriene MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe betamethasone dipropionate MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe betamethasone
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.643 MG/ML (expressed as betamethasone dipropionate) / 0.05 MG/ML ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES VUID 4035293 NAMES Prescribable Synonym calcipotriene 0.005 % / betamethasone propionate 0.064 % Topical Foam SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon SOURCES Source National Drug Data File Plus Source Vocabulary SOURCES Source Veterans Health Administration National Drug File